Asymptomatic COVID19 in Education (ACE) Cohort

Project summary:

The aim of ACE study, in collaboration with the University of Birmingham, University of Cambridge and Cardiff University, is to examine the immune responses to vaccination in young adults. Specifically, the study will examine any synergistic effects of prior infection with SARS-CoV2, either asymptomatically or symptomatically, on the humoral immune responses in both local (salivary) or systemic (blood) samples. In a subset we will also deep phenotype T cell responses to examine immunological memory generated. 

Funders

The National Core Studies Programme

Leader researcher:

Professor Lucy Fairclough

Lead institution:

The University of Nottingham

Vaccine type:

AstraZeneca
Pfizer

Recruitment for clinical trial open:

Yes